Yasmin Saad Selected Research

Yasmin Saad Research Topics

7	Chronic Hepatitis C 01/2020 - 08/2013
4	Fibrosis (Cirrhosis) 11/2014 - 08/2013
2	Chronic Renal Insufficiency 02/2023 - 01/2019
2	Anemia 02/2023 - 01/2019
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2020 - 09/2013
2	Hepatitis C 12/2013 - 11/2013
1	COVID-19 01/2022
1	Coinfection 01/2022
1	Neoplasms (Cancer) 01/2022
1	Non-alcoholic Fatty Liver Disease 12/2021
1	Hepatitis 03/2018
1	Infections 11/2014
1	Hepatocellular Carcinoma (Hepatoma) 12/2013
1	Carcinogenesis 09/2013
1	Insulin Resistance 08/2013
1	Ischemia 04/2012
1	End Stage Liver Disease 04/2012

3	Ribavirin (Virazole)FDA LinkGeneric 02/2023 - 11/2013
3	Antiviral Agents (Antivirals)IBA 01/2020 - 09/2014
2	Ritonavir (Norvir)FDA Link 02/2023 - 01/2019
2	paritaprevirIBA 02/2023 - 01/2019
2	ombitasvirIBA 02/2023 - 01/2019
2	Messenger RNA (mRNA)IBA 12/2013 - 09/2013
1	MineralsIBA 01/2022
1	VitaminsIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 12/2021
1	EndocannabinoidsIBA 12/2021
1	anandamide (arachidonylethanolamide)IBA 12/2021
1	Indicators and Reagents (Reagents)IBA 12/2021
1	AlbuminsIBA 01/2020
1	RNA (Ribonucleic Acid)IBA 11/2014
1	microsomal triglyceride transfer proteinIBA 11/2014
1	Genetic Markers (Genetic Marker)IBA 12/2013
1	Transaminases (Aminotransferases)IBA 11/2013
1	CaspasesIBA 09/2013
1	Proteins (Proteins, Gene)FDA Link 09/2013
1	LeptinIBA 08/2013
1	AdiponectinIBA 08/2013
1	AdipokinesIBA 08/2013
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 08/2013
1	HLA Antigens (Human Leukocyte Antigens)IBA 04/2012
1	SteroidsIBA 04/2012

9	Therapeutics 02/2023 - 08/2013
1	Drug Therapy (Chemotherapy) 01/2022
1	Blood Transfusion (Blood Transfusions) 01/2019
1	Operative Time 04/2012